Kalii Chloridum/Natrii Chloridum B. Braun

Potassium chloride and sodium chloride, the active ingredients in Kalii Chloridum/Natrii Chloridum B. Braun, are electrolyte supplements presented as an injection solution for intravenous use. They are employed to correct electrolyte depletion, such as hypokalemia and hyponatremia, in hospitalized patients who require rapid fluid and ion balance restoration.

GNH USA supplies Kalii Chloridum/Natrii Chloridum B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kalii Chloridum/Natrii Chloridum B. Braun is an intravenous electrolyte supplement used to address disorders of potassium and sodium balance.

- Electrolyte depletion: restores normal potassium and sodium concentrations in patients with overall electrolyte loss. - Hypokalemia: raises low serum potassium levels to prevent cardiac and muscular complications. - Hyponatremia: increases serum sodium to correct dilutional hyponatremia. - Fluid replacement: provides essential ions as part of volume resuscitation in acute care settings.

Adverse reactions may occur with intravenous electrolyte administration.

Common Side Effects: - Mild vein irritation at the infusion site. - Transient nausea or vomiting. - Temporary headache. - Mild dizziness. - Slight increase in blood pressure. - Mild muscle cramps.

Serious or Rare Side Effects: - Hyperkalemia leading to cardiac arrhythmia. - Hypernatremia causing neurological disturbances. - Severe allergic reaction (anaphylaxis). - Phlebitis or thrombophlebitis. - Electrolyte imbalance with metabolic acidosis. - Renal impairment exacerbation.

When using Kalii Chloridum/Natrii Chloridum B. Braun, clinicians should consider several safety measures.

- Patient assessment: evaluate baseline electrolyte levels and renal function before administration. - Infusion rate: avoid rapid infusion to reduce risk of cardiac events. - Monitoring: continuously monitor cardiac rhythm and serum electrolytes during therapy. - Contraindications: do not use in patients with known hypersensitivity to the formulation. - Compatibility: ensure compatibility with other IV solutions before mixing. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Electrolyte therapy can interact with other medications, requiring careful review.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may potentiate hyperkalemia. - Potassium‑sparing diuretics: increase risk of elevated serum potassium. - Sodium‑containing medications: can exacerbate hypernatremia.

Moderate Interactions (Monitor Closely): - Digoxin: altered potassium levels affect digoxin toxicity. - NSAIDs: may impair renal excretion of electrolytes. - Insulin: shifts potassium intracellularly, requiring electrolyte monitoring.